URGN position history
The shares of Urogen Pharma (URGN) that Opaleye Management Inc. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2022 Q2: 238,670 shares, $2M, 0.88% of portfolio, New
- 2022 Q3: 397,500 shares, $3.3M, 1.4% of portfolio, Add +66.5%
- 2022 Q4: 488,656 shares, $4.3M, 1.5% of portfolio, Add +22.9%
- 2023 Q1: 505,000 shares, $4.7M, 1.4% of portfolio, Add +3.3%
- 2023 Q2: 570,000 shares, $5.9M, 1.4% of portfolio, Add +12.9%
- 2023 Q3: 320,000 shares, $4.5M, 1.5% of portfolio, Reduce −43.9%
- 2023 Q4: 320,000 shares, $4.8M, 1.3% of portfolio
- 2024 Q1: 540,000 shares, $8.1M, 1.8% of portfolio, Add +68.8%
- 2024 Q2: 412,000 shares, $6.9M, 1.6% of portfolio, Reduce −23.7%
- 2024 Q3: 404,100 shares, $5.1M, 0.86% of portfolio, Reduce −1.9%
- 2024 Q4: 220,000 shares, $2.3M, 0.41% of portfolio, Reduce −45.6%
- 2025 Q1: not held, Exit
- 2025 Q2: not held
- 2025 Q3: not held
- 2025 Q4: 536,846 shares, $13M, 1.7% of portfolio, New
- 2026 Q1: 1,430,000 shares, $26M, 3.4% of portfolio, Add +166.4%
- 2026 Q2: 1,439,996 shares, $53M, 4.8% of portfolio, Add +0.7%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|